Literature DB >> 21246721

Development and application of high-performance liquid chromatography for the study of ampelopsin pharmacokinetics in rat plasma using cloud-point extraction.

Jun Zhou1, Ping Zeng, Hong Hai Tu, Feng Qiao Wang.   

Abstract

A simple, rapid and specific method based on cloud-point extraction (CPE) was developed to determine ampelopsin in rat plasma after oral administration by reversed-phase high-performance liquid chromatography. The non-ionic surfactant Genapol X-080 was chosen as the extract solvent. Some important parameters affecting the CPE efficiency, such as the nature and concentration of surfactant, extraction temperature and time, centrifuge time and salt effect, were investigated and optimized. Separation was accomplished using a C(18) column by gradient elution with a acetonitrile-phosphate buffer solution as the mobile phase. The detection wavelength was set at 290 nm. Under optimum conditions, the linear range of ampelopsin in rat plasma was 20-2000 ng/mL (r(2)=0.9996). The limit of detection was 6 ng/mL (S/N=3) with the limit of quantification being 20 ng/mL (S/N=10). The proposed method has been successfully applied for pharmacokinetic studies of ampelopsin from rat plasma after oral administration.
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21246721     DOI: 10.1002/jssc.201000382

Source DB:  PubMed          Journal:  J Sep Sci        ISSN: 1615-9306            Impact factor:   3.645


  2 in total

1.  Dihydromyricetin inhibits migration and invasion of hepatoma cells through regulation of MMP-9 expression.

Authors:  Qing-Yu Zhang; Ran Li; Guo-Fang Zeng; Bin Liu; Jie Liu; Yang Shu; Zhong-Kao Liu; Zhi-Dong Qiu; Dong-Jun Wang; Hui-Lai Miao; Ming-Yi Li; Run-Zhi Zhu
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

Review 2.  Nanomicellar Extraction of Polyphenols-Methodology and Applications Review.

Authors:  Paweł Śliwa; Karolina Śliwa
Journal:  Int J Mol Sci       Date:  2021-10-21       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.